Team:UCL London/Project Description

From 2010.igem.org

(Difference between revisions)
(Project Description)
Line 18: Line 18:
<html>
<html>
-
<object width="960" height="745"><param name="movie" value="http://www.youtube.com/v/bmgbL9Q0_hQ?fs=1&amp;hl=en_US&amp;color1=0xe1600f&amp;color2=0xfebd01"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="http://www.youtube.com/v/bmgbL9Q0_hQ?fs=1&amp;hl=en_US&amp;color1=0xe1600f&amp;color2=0xfebd01" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" width="960" height="745"></embed></object>
+
<object width="920" height="745"><param name="movie" value="http://www.youtube.com/v/bmgbL9Q0_hQ?fs=1&amp;hl=en_US&amp;color1=0xe1600f&amp;color2=0xfebd01"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="http://www.youtube.com/v/bmgbL9Q0_hQ?fs=1&amp;hl=en_US&amp;color1=0xe1600f&amp;color2=0xfebd01" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" width="920" height="745"></embed></object>
</html>
</html>
{{:Team:UCL_London/templates/v2/footerFullWidth}}
{{:Team:UCL_London/templates/v2/footerFullWidth}}

Revision as of 22:38, 18 September 2010

UCL IGEM 2010

RETURN TO IGEM 2010

Project Hypoxon

Project Abstract

UCL-LabTeam.JPG

Synthetic biology is now in a position to overcome many, hitherto, cumbersome and resource consuming manufacturing tasks. Society has now accepted the advent of such entities as recombinant insulin , monoclonal antibodies etc as essential for the future well being of human life. We can now use the bio engineered tools available to us to create systems which make manufacturing health or environmentally associated products simpler and more economical.

To this end, this project addresses the hypothesis that we can use auto-induction as a means of control of production of recombinant products at a pre-destined time in large production vessels thus alleviating the need for extra resources. To illustrate this we are using E.coli as our main vehicle with the prospect of removing the need for IPTG induction as a mechanism for the production of a vast array of biopharmaceuticals. We expect this technology to be equally applicable to other systems such as yeast and mammalian cells.

Project Description

Thnaks to the efforts of our artists, we managed to summarise what we hoped to achieve in the lab in a simple and animation;


Retrieved from "http://2010.igem.org/Team:UCL_London/Project_Description"